Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuLeNing vs Glucophage in Type 2 Diabetes
NCT03039075Phase 4Completed
- Sponsor
- Chongqing Medical University
- Start
- Nov 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of DuLeNing in type 2 diabetes mellitus (T2DM), sponsored by Chongqing Medical University. Started Nov 2016; status: completed.
02
Drugs
DuLeNing
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03039075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03039075.